Feliza Mirasol is the science editor for 

Articles

In the collaboration, the new company, Oblenio Bio, has been granted an exclusive option to license LBL-051, a tri-specific T-cell engager antibody, from Leads Biolabs.

Oblenio Bio Created by Aditum Bio and Leads Biolabs to Develop Therapeutic Antibody for Treating Autoimmune Disorders

A genetic medicines customer has selected the company’s binders for commercial development of the customer’s product.

Aptamer Extends Agreement for Drug Delivery Vehicles

The merger agreement is valued at approximately $1.1 billion.

Avid Bioservices Acquired by GHO Capital Partners and Ampersand Capital Partners

Synaffix, a Lonza company, has licensed its ADC technology to BigHat Biosciences to be combined with the latter's ML design platform to develop new ADCs

Synaffix, a Lonza Company, Collaborates with BigHat Biosciences on ADCs Designed Using Machine Learning

Chris Burgess, PhD, is an analytical scientist at Burgess Analytical Consultancy Limited, ‘Rose Rae,’ The Lendings, Startforth, Barnard Castle, Co Durham, DL12 9AB, UK; Tel: +44 1833 637 446; chris@burgessconsultancy.com; www.burgessconsultancy.co

Data governance, data integrity, and data quality are all widely used terms, but what do they actually mean and how are they connected?

Data Governance, Data Integrity, and Data Quality: What’s the Connection?

Mike Hennessy Jr. is the Chairman and CEO of 

Recent hurricanes in the US close Baxter plant, shining a spotlight on supply chain fragility again.

Weathering the Storms

Siegfried Schmitt, PhD, is Vice President Technical at Parexel International, Siegfried.Schmitt@parexel.com.

The product license holder must have a supplier oversight system in place, says Siegfried Schmitt, PhD, vice president, Technical, Parexel.

The Importance of Appropriate Supplier Oversight 

CDER Director Patrizia Cavazzoni and CBER Director Peter Marks provided an update on the rare disease innovation hub in a new FDA Voices blog post.

FDA Rare Disease Innovation Moves Forward

Patrick Lavery is an Editor for the MJH Life Sciences brands 

. Previously at MJH, he filled the same role for 

The system is Hapman’s first major product launch since 2008, following a year of intensive R&D that builds upon the company’s eight decades of tubular drag conveyor expertise.

Hapman to Showcase New Conveyor at Pack Expo 2024

With DKK 600 million (US$87.4 million) in funding from the Novo Nordisk Foundation, the new supercomputer offers the potential to accelerate innovation in drug discovery.

News